Position in TMO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,179,198
+$687,177 QoQ
Shares Held
2,352
+135.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
#1,370
of 2,602 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ELEVATUS WELATH MANAGEMENT holds $3,470,975 across 6 Diagnostics & Research names. TMO ranks #1 (34.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
2,352 | $1,179,198 | |
| 2 | DHR |
Danaher Corp /De/
|
3,246 | $618,298 | |
| 3 | NTRA |
Natera, Inc.
|
2,019 | $548,057 | |
| 4 | A |
Agilent Technologies, Inc.
|
3,795 | $504,089 | |
| 5 | RVTY |
Revvity, Inc.
|
3,531 | $392,859 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
434 | $228,474 |
All Filings in TMO
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,179,198 | 2,352 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $492,021 | 1,001 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $569,599 | 983 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $476,774 | 983 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $399,378 | 985 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $548,355 | 1,102 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $572,773 | 1,101 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $681,045 | 1,101 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $673,001 | 1,217 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $706,751 | 1,216 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $629,516 | 1,186 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $591,206 | 1,168 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $581,751 | 1,115 | Shares | Sole | 2023-08-08 | |
| No filing history on record for this holder in this stock. | ||||||